Category Archives: C. Difficile Toxins

See posts about List Biological Laboratories, Inc. C. Difficile Toxins

Toxoids, Toxins and Vaccine Related Terminology

March 19, 2018
  |

By: Mary N. Wessling, Ph.D. ELS List Biological Laboratories’ (List Labs) catalog of products is related to furthering research in human health and preventing disease, most commonly as the starting materials for vaccine research & development or production around the world….

List Labs Reagents Used in Research – January ’18

January 8, 2018
  |

By: Rachel Berlin, Marketing Manager The List Labs website hosts a library of scientific article abstracts related to the research performed using our products called the Citations Page. Visitors can search this library to learn how others have used List Labs’ reagents in…

How List Biological Laboratories, Inc. got its start

August 29, 2017
  |

The origin of businesses is often an interesting story. List Biological Laboratories is no exception. The company was founded in 1978 by Linda Shoer. Linda was an entrepreneurial scientist in Silicon Valley, who’d been relocated with her husband from Boston….

C. Difficile Toxins A and B Support Development of Diagnostics

February 14, 2017
  |

By: Mary N. Wessling, Ph.D. ELS List Biological Laboratories, Inc.’s products are being used to confront one of the most pressing problems in health care today: stopping the worldwide spread of illness caused by Clostridium difficile (CD, C Difficile Toxin), a…

List Products for Microbiome Research and Discovery

March 16, 2015
  |

By: Suzanne Canada, Ph.D. Tanager Medical Writing While you go about your day, you are surrounded by micro-organisms.  Although most of us spend a lot of time washing up and trying not to think about the propensity of creatures that…